This is a research study for people diagnosed with High Risk Myelofibrosis. The purpose of this study is to see if the study drug BMS-986158 works better alone or in combination with ruxolitinib or fedratinib.
COM_RESEARCHSTUDIES_DETAIL_HEADER_BASIC_CONTACT_4
North Carolina (Statewide)
Brandi Reeves
LCCC - Clinical Trials
Clinical or Medical
Interventional
Cancer (Leukemia)
23-0758
Copyright © 2013-2022 The NC TraCS Institute, the integrated home of the NIH Clinical and Translational Science Awards (CTSA) Program at UNC-CH. This website is made possible by CTSA Grant UL1TR002489 and the National Center for Advancing Translational Sciences.
Questions?
